These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15102782)

  • 1. Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria.
    Grangette C; Müller-Alouf H; Hols P; Goudercourt D; Delcour J; Turneer M; Mercenier A
    Infect Immun; 2004 May; 72(5):2731-7. PubMed ID: 15102782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.
    Grangette C; Müller-Alouf H; Geoffroy M; Goudercourt D; Turneer M; Mercenier A
    Vaccine; 2002 Sep; 20(27-28):3304-9. PubMed ID: 12213400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the development of Lactococcus lactis as a recombinant mucosal vaccine delivery system.
    Norton PM; Le Page RW; Wells JM
    Folia Microbiol (Praha); 1995; 40(3):225-30. PubMed ID: 8919927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.
    Robinson K; Chamberlain LM; Lopez MC; Rush CM; Marcotte H; Le Page RW; Wells JM
    Infect Immun; 2004 May; 72(5):2753-61. PubMed ID: 15102785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations.
    Reveneau N; Geoffroy MC; Locht C; Chagnaud P; Mercenier A
    Vaccine; 2002 Mar; 20(13-14):1769-77. PubMed ID: 11906764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
    Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
    Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine.
    Steidler L; Robinson K; Chamberlain L; Schofield KM; Remaut E; Le Page RW; Wells JM
    Infect Immun; 1998 Jul; 66(7):3183-9. PubMed ID: 9632584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactic acid bacteria as live vaccines.
    Mercenier A; Müller-Alouf H; Grangette C
    Curr Issues Mol Biol; 2000 Jan; 2(1):17-25. PubMed ID: 11464916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.
    Grangette C; Müller-Alouf H; Goudercourt D; Geoffroy MC; Turneer M; Mercenier A
    Infect Immun; 2001 Mar; 69(3):1547-53. PubMed ID: 11179325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis.
    Norton PM; Brown HW; Wells JM; Macpherson AM; Wilson PW; Le Page RW
    FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):167-77. PubMed ID: 8809553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli.
    Shaw DM; Gaerthé B; Leer RJ; Van Der Stap JG; Smittenaar C; Heijne Den Bak-Glashouwer M; Thole JE; Tielen FJ; Pouwels PH; Havenith CE
    Immunology; 2000 Aug; 100(4):510-8. PubMed ID: 10929079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
    Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
    Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of the nisin-controlled expression system in Lactobacillus plantarum: a tool to study in vivo biological effects.
    Pavan S; Hols P; Delcour J; Geoffroy MC; Grangette C; Kleerebezem M; Mercenier A
    Appl Environ Microbiol; 2000 Oct; 66(10):4427-32. PubMed ID: 11010894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.
    Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG
    Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress on lactococcus lactis expressing heterologous antigens as live mucosal vaccines].
    Shi D; Song Y; Li YJ
    Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):680-3. PubMed ID: 17037080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein.
    Rodríguez-Díaz J; Montava R; Viana R; Buesa J; Pérez-Martínez G; Monedero V
    Biotechnol Lett; 2011 Jun; 33(6):1169-75. PubMed ID: 21302132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
    Corthésy B; Boris S; Isler P; Grangette C; Mercenier A
    J Infect Dis; 2005 Oct; 192(8):1441-9. PubMed ID: 16170763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge.
    Wells JM; Wilson PW; Norton PM; Gasson MJ; Le Page RW
    Mol Microbiol; 1993 Jun; 8(6):1155-62. PubMed ID: 8361360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
    Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
    Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
    Oliveira ML; Arêas AP; Campos IB; Monedero V; Perez-Martínez G; Miyaji EN; Leite LC; Aires KA; Lee Ho P
    Microbes Infect; 2006 Apr; 8(4):1016-24. PubMed ID: 16549380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.